Surrey researchers Sign in
Acquisition of Mutated BRAF Is as a Major Effector of Melanoma Recurrence Which Can Be Targeted By Immuno- or Chemo-Therapy
Conference presentation   Peer reviewed

Acquisition of Mutated BRAF Is as a Major Effector of Melanoma Recurrence Which Can Be Targeted By Immuno- or Chemo-Therapy

S Zaidi, M Blanchard, K Shim, E Ilett, T Kottke, J Thompson, E Celis, H Pandha, P Selby, A Melcher, …
MOLECULAR THERAPY, Vol.22, pp.S245-S245
17th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT) (Washington, DC, 21/05/2014 - 24/05/2014)
01/05/2014

Abstract

Science & Technology Life Sciences & Biomedicine Biotechnology & Applied Microbiology Genetics & Heredity Medicine Research & Experimental Research & Experimental Medicine
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000337231300628&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

31 Record Views

Details

Usage Policy